Stockreport

Apollo Medical upgraded to buy at BoA on revenue, earnings growth [Seeking Alpha]

Apollo Medical Holdings, Inc.  (AMEH) 
NASDAQ:AMEX Investor Relations: apollomed.net
PDF path to sustaining 30-40%+ revenue and 20%+ EBITDA growth through at least 2026." The firm has increased the price target to $55 from $44 (~42% upside based on Wednesd [Read more]